BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,070 filers reported holding BAXTER INTL INC in Q3 2021. The put-call ratio across all filers is 0.84 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $99,000 | -14.7% | 1,282 | -4.8% | 0.02% | 0.0% |
| Q4 2021 | $116,000 | +7.4% | 1,346 | 0.0% | 0.02% | 0.0% |
| Q3 2021 | $108,000 | -0.9% | 1,346 | -1.0% | 0.02% | +5.3% |
| Q2 2021 | $109,000 | -5.2% | 1,360 | 0.0% | 0.02% | -17.4% |
| Q1 2021 | $115,000 | +5.5% | 1,360 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $109,000 | +1.9% | 1,360 | +2.3% | 0.02% | -11.5% |
| Q3 2020 | $107,000 | -6.1% | 1,330 | +0.4% | 0.03% | -10.3% |
| Q2 2020 | $114,000 | +1.8% | 1,325 | -4.2% | 0.03% | -19.4% |
| Q1 2020 | $112,000 | +1.8% | 1,383 | +4.9% | 0.04% | +20.0% |
| Q4 2019 | $110,000 | -4.3% | 1,319 | +0.3% | 0.03% | -14.3% |
| Q3 2019 | $115,000 | +6.5% | 1,315 | 0.0% | 0.04% | +2.9% |
| Q2 2019 | $108,000 | +2.9% | 1,315 | +1.7% | 0.03% | -10.5% |
| Q1 2019 | $105,000 | +23.5% | 1,293 | 0.0% | 0.04% | +8.6% |
| Q4 2018 | $85,000 | -15.0% | 1,293 | 0.0% | 0.04% | -2.8% |
| Q3 2018 | $100,000 | +5.3% | 1,293 | 0.0% | 0.04% | -2.7% |
| Q2 2018 | $95,000 | +13.1% | 1,293 | 0.0% | 0.04% | +15.6% |
| Q1 2018 | $84,000 | 0.0% | 1,293 | 0.0% | 0.03% | -3.0% |
| Q4 2017 | $84,000 | +3.7% | 1,293 | 0.0% | 0.03% | -8.3% |
| Q3 2017 | $81,000 | +5.2% | 1,293 | +1.8% | 0.04% | -5.3% |
| Q2 2017 | $77,000 | +16.7% | 1,270 | 0.0% | 0.04% | +11.8% |
| Q1 2017 | $66,000 | +17.9% | 1,270 | 0.0% | 0.03% | +6.2% |
| Q4 2016 | $56,000 | -6.7% | 1,270 | 0.0% | 0.03% | -17.9% |
| Q3 2016 | $60,000 | +5.3% | 1,270 | 0.0% | 0.04% | -4.9% |
| Q2 2016 | $57,000 | +9.6% | 1,270 | 0.0% | 0.04% | +5.1% |
| Q1 2016 | $52,000 | +8.3% | 1,270 | +0.6% | 0.04% | 0.0% |
| Q4 2015 | $48,000 | +14.3% | 1,263 | -1.8% | 0.04% | +2.6% |
| Q3 2015 | $42,000 | -53.3% | 1,286 | +0.4% | 0.04% | -51.3% |
| Q2 2015 | $90,000 | +2.3% | 1,281 | 0.0% | 0.08% | +1.3% |
| Q1 2015 | $88,000 | -6.4% | 1,281 | 0.0% | 0.08% | -11.5% |
| Q4 2014 | $94,000 | 0.0% | 1,281 | -2.3% | 0.09% | +2.4% |
| Q3 2014 | $94,000 | +1.1% | 1,311 | +1.3% | 0.08% | +2.4% |
| Q2 2014 | $93,000 | -45.0% | 1,294 | -44.2% | 0.08% | -44.7% |
| Q1 2014 | $169,000 | +5.0% | 2,317 | 0.0% | 0.15% | +11.9% |
| Q4 2013 | $161,000 | – | 2,317 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 200,000 | $7,548,000 | 6.60% |
| BOONE CAPITAL MANAGEMENT LLC | 469,405 | $17,715,345 | 5.59% |
| Soditic Asset Management LLP | 186,920 | $7,054,361 | 5.43% |
| JONES ROAD CAPITAL MANAGEMENT, L.P. | 131,000 | $4,943,940 | 4.32% |
| Camber Capital Management LP | 3,000,000 | $113,220 | 3.73% |
| Carmignac Gestion | 4,848,773 | $182,991,718 | 3.36% |
| SHAPIRO CAPITAL MANAGEMENT LLC | 3,028,799 | $114,306,874 | 3.33% |
| Hillman Capital Management, Inc. | 219,248 | $8,274,420 | 3.19% |
| Cincinnati Specialty Underwriters Insurance CO | 201,500 | $7,604,610 | 2.90% |
| Callodine Capital Management, LP | 265,000 | $10,001,100 | 2.79% |